Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Ribonucleases H (RNases H) are endonucleolytic enzymes, evolutionarily related to retroviral integrases, DNA transposases, resolvases and numerous nucleases. RNases H cleave RNA in RNA/DNA hybrids and their activity plays an important role in the replication of prokaryotic and eukaryotic genomes, as well as in the replication of reverse-transcribing viruses. During reverse transcription, the RNase H activity of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) degrades the viral genomic RNA to facilitate the synthesis of viral double-stranded DNA. HIV and HBV reverse transcriptases contain DNA polymerase and RNase H domains that act in a coordinated manner to produce double-stranded viral DNA. Although RNase H inhibitors have not been developed into licensed drugs, recent progress has led to the identification of a number of small molecules with inhibitory activity at low micromolar or even nanomolar concentrations. These compounds can be classified into metal-chelating active site inhibitors and allosteric inhibitors. Among them, α-hydroxytropolones, N-hydroxyixoquinolinediones and N-hydroxypyridinediones represent chemotypes active against both HIV and HBV RNases H. In this review we summarize recent developments in the field including the identification of novel RNase H inhibitors, compounds with dual activity, broad specificity and efforts to decrease their toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A general two-metal-ion mechanism for catalytic RNA
Steitz, T. A., & Steitz, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6498 · Cited by 1,171 · cited 1×
“Reactions occur through the formation of a pentavalent intermediate and inversion of the phosphate stereo configuration (Steiz and Steitz, 1993; Yang et al., 2006).”
BackgroundDyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“Very early in antiretroviral drug discovery, the structure of another HIV-1 enzyme, IN, member of the same polynucleotidyltransferase family, was partially solved (Dyda et al., 1994).”
BackgroundThree-dimensional structure of ribonuclease H from E. coli
Katayanagi, K., Miyagawa, M., Matsushima, M., Ishikawa, M., Kanaya, S., Ikehara, M., Matsuzaki, T., & Morikawa, K. (1990) · Nature · doi:10.1038/347306a0 · Cited by 349
Nowotny, M., & Yang, W. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601076 · Cited by 250 · cited 1×
“Under physiological conditions, the preferred cation is Mg, although Mn also supports catalysis, while Ca inhibits cleavage (Rosta et al., 2014; Nowotny and Yang, 2006).”
BackgroundMÖLLING, K., BOLOGNESI, D. P., BAUER, H., BÜSEN, W., PLASSMANN, H. W., & HAUSEN, P. (1971) · Nature New Biology · doi:10.1038/newbio234240a0 · Cited by 227 · cited 1×
“Soon after the discovery of retroviral RTs, its associated RNase H activity was identified as an essential component of the enzyme (Mölling et al., 1971).”
BackgroundTadokoro, T., & Kanaya, S. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06907.x · Cited by 202
Retroviral integrase superfamily: the structural perspective
Nowotny, M. (2009) · The EMBO Reports · doi:10.1038/embor.2008.256 · Cited by 183 · cited 1×
“In addition to the central β-sheet, the folds contain α-helices at different positions and arrangement (Nowotny, 2009; Majorek et al., 2014; Hyjek, et al. 2019).”
BackgroundRNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
DeStefano, J. J., Buiser, R. G., Mallaber, L. M., Myers, T. W., Bambara, R. A., & Fay, P. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89464-2 · Cited by 146
Menéndez-Arias, L., Sebastián-Martín, A., & Álvarez, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.019 · Cited by 123 · cited 4×
“Reverse transcription shows remarkable differences in HBV compared to HIV and other retroviruses (Figure 1) (Hu and Seeger, 2015; Menéndez-Arias et al., 2017).”
BackgroundMethodInfluentialSelf-citation
Cited by
Avoiding drug resistance in HIV reverse transcriptase
Cilento, M. E., Kirby, K. A., & Sarafianos, S. G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00967 · Cited by 106
Desantis, J., Massari, S., Corona, A., Astolfi, A., Sabatini, S., Manfroni, G., Palazzotti, D., Cecchetti, V., Pannecouque, C., Tramontano, E., et al. (2020) · Molecules · doi:10.3390/molecules25051183 · Cited by 29
Self-citationCorona, A., Onnis, V., Del Vecchio, C., Esposito, F., Cheng, Y.-C., & Tramontano, E. (2020) · Molecules · doi:10.3390/molecules25061338 · Cited by 19
Self-citationFois, B., Corona, A., Tramontano, E., Distinto, S., Maccioni, E., Meleddu, R., Caboni, P., Floris, C., & Cottiglia, F. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1887170 · Cited by 7
“Acid hydrolysis of the inactive teuflavoside provided three undescribed neo-clerodanes, flavuglaucins A-C (7-9) and one known neo-clerodane (10).”
BackgroundSelf-citation
Metadata
- Authors
- Tramontano, E., Corona, A., & Menéndez-Arias, L.
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 171
- Pages
- 104613
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W2974535357
- Cited by
- 53
- References
- 16
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. https://app.cochat.ai/papers/10.1016/j.antiviral.2019.104613
- The paper
- Tramontano, E., Corona, A., & Menéndez-Arias, L. (2019). Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. Antiviral Research. https://doi.org/10.1016/j.antiviral.2019.104613
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.